selected scholarly activity
-
chapters
- Investigation of Acute Transfusion Reactions. 77-90. 2022
- Investigation of Acute Transfusion Reactions. 69-80. 2017
- Acetylsalicylic acid for the prevention and treatment of thromboembolic diseases. 619-633. 2016
- Red cell, platelet, and white cell antigens. 509-546. 2013
- Investigation of Acute Transfusion Reactions. 63-76. 2013
- Disorders of platelet number and function. 4506-4518. 2010
- Investigation of Acute Transfusion Reactions. 61-71. 2009
- Chapter 50 Febrile, Allergic, and Other Noninfectious Transfusion Reactions. 677-690. 2007
- Chapter 51 Transfusion-Related Acute Lung Injury. 691-700. 2007
- Febrile, Allergic, and Other Noninfectious Transfusion Reactions. 677-690. 2007
- Transfusion-Related Acute Lung Injury. 691-700. 2007
- Thrombocytopenia in pregnancy. 374-392. 2006
- Venous thrombosis in pregnancy. 312-336. 2006
- Febrile, Allergic, and Other Noninfectious Transfusion Reactions. 677-690. 2006
- Transfusion-Related Acute Lung Injury. 691-700. 2006
- Thrombocytopenia in pregnancy. 490-505. 2006
- Immune-mediated thrombocytopenia. 542-555. 2002
-
conferences
- An evaluation of the clinical impacts of 7‐day platelets. Transfusion. 480-493. 2023
- A Prospective Interventional Study of Blood Bank Technologist Screening of Red Blood Cell Orders. Transfusion. 192A-193A. 2020
- Transfusion Reactions Following the Implementation of Seven Day Platelets. Transfusion. 256A-256A. 2020
- Anti-CD20 Monoclonal Antibody Therapy for Immune Modulation Across a Range of Autoimmune Diseases. Blood. 2017
- Analysis of Red Blood Cell Storage Duration and in-Hospital Mortality Using Time Dependent Exposure: Is the Oldest Blood Bad?. Transfusion. 33A-33A. 2017
- BloodBrief: Increasing Awareness to Influence Transfusion Practice. Transfusion. 207A-207A. 2016
- Informing Fresh Versus Old Red Cell Management (INFORM) Trial: A Large International Pragmatic Randomized Trial. Transfusion. 5A-5A. 2016
- Understanding Hospital Inventory. Transfusion. 239A-239A. 2016
- A Repeat Provincial Audit of Frozen Plasma (FP) and Prothrombin Complex Concentrates (PCCs). Transfusion. 162A-162A. 2015
- Exploratory Analysis of a Blood Processing Method and In-hospital Mortality. Transfusion. 23A-23A. 2015
- A Phase II Study Evaluating the Efficacy of Rituximab in the Management of Patients with Relapsed or Refractory TTP. Blood. 4191-4191. 2014
- High Rates of Inappropriate Frozen Plasma Utilization Based on Expert Medical Rating; Results of a Multicentre Canadian Study. Transfusion. 113A-113A. 2012
- Patterns of factor concentrate prophylaxis in adults with severe hemophilia: A multicentre Canadian study. Haemophilia. 831-831. 2012
- Low bone mineral density and increased fat mass in boys with severe hemophilia. Haemophilia. 23-23. 2012
- Nutritional intake and bone mineral density in boys with severe hemophilia. Haemophilia. 23-23. 2012
- Osteochondral Lesions of the Ankle Joint in Patients with Hemophilia A: A Retrospective Case Series. Haemophilia. 128-128. 2012
- The Canadian experience: Severe factor V deficiency. Haemophilia. 184-185. 2012
- Understanding Health and Treatment Decision-Making among Youth with Hemophilia: A Qualitative Approach. Haemophilia. 207-207. 2012
- What do Canadian men living with hemophilia need to know to facilitate optimal disease management? A mixed methods approach. Haemophilia. 175-175. 2012
- Understanding Health and Treatment Decision-Making among Youth with Severe Hemophilia: a Qualitative Approach. International Journal of Qualitative Methods. 791-792. 2012
- A Pilot Study Evaluating the Effects of Intravenous Immunoglobulin (IVIG) Administration on Serological Test Results and Adverse Events. Transfusion. 154A-154A. 2011
- Can We Do a 25,000 Patient Pragmatic Study to Address the Age of Blood and Mortality Controversy? A Pilot to Determine Feasibility. Transfusion. 193A-193A. 2011
- Utilizing Automation to Improve Blood Product Delivery to Patients. Transfusion. 267A-267A. 2011
- A prospective cohort study of bleeding symptoms among persons referred to hematologists who are diagnosed with or excluded of having bleeding disorders. Journal of Thrombosis and Haemostasis. 687-688. 2011
- Bleeding risks associated with inherited platelet disorders: results from a prospective cohort study. Journal of Thrombosis and Haemostasis. 687-687. 2011
- Dosing decisions in severe hemophilia a: can we aim lower? FVIII use in a cohort of Canadian patients in 2009. Journal of Thrombosis and Haemostasis. 681-681. 2011
- First analysis of 10-year trend in national factor concentrates usage in hemophilia: data from the Canadian hemophilia assessment and resource management system. Journal of Thrombosis and Haemostasis. 744-745. 2011
- Bleeding symptoms and risks in undefined bleeding disorders: results from a prospective study. Haemophilia. 562-562. 2011
- The year in review: describing prophylaxis and adherence in children with severe hemophilia A using patient infusion diaries. Haemophilia. 125-125. 2010
- Diagnostic Utility of Platelet Secretion Testing by ATP Release Assays: Results From a Prospective Study of Individuals Referred for Bleeding Disorder Assessments.. Blood. 537-538. 2009
- Evidence of Patient Specific HLA Antibodies in Canadian TRALI Cases Classified by the 2004 Canadian Consensus Conference Definition. Transfusion. 45A-45A. 2009
- Impact of Just In Time (JIT) Delivery of Blood Products on the Crossmatch/Transfusion (C/T) Ratio. Transfusion. 268A-268A. 2009
- Laboratory Information System - The Key Enabler to Consolidating Transfusion Services. Transfusion. 303A-303A. 2009
- TRALI Prevention at Canadian Blood Services: The Evolving Process and Its Impact on TRALI Cases in Canada. Transfusion. 47A-47A. 2009
- The Development of a Bleeding Severity Measurement Scale (BSMS): A New Measurement Tool. Transfusion. 165A-165A. 2009
- Bruising in inherited disorders of primary hemostasis: results from a prospective study. Journal of Thrombosis and Haemostasis. 1155-1156. 2009
- Evaluation of a method to assess platelet function in individuals with thrombocytopenia. Haemophilia. 626-626. 2009
- A Canadian phase II study evaluating the efficacy of rituximab in the management of patients with relapsed/refractory thrombotic thrombocytopenic purpura. Kidney International, Supplement. S55-S58. 2009
- Evaluation of cardiac testing at decreased temperature. Transfusion. 77A-78A. 2008
- Implementation of just in time delivery of blood products in a multi-site academic facility. Transfusion. 262A-262A. 2008
- Use of the medical event reporting system to track sample labeling errors and wrong blood in tube. Transfusion. 290A-290A. 2008
- Launch of toll free telephone line. Haemophilia. 132-132. 2008
- The prevalence of patients with inhibitor antibodies in Canadians with hemophilia A and B, with application of a new clinical classification system. Haemophilia. 56-56. 2008
- Gender differences in bleeding problems and implications for the assessment of a bleeding disorder. Blood. 639A-639A. 2007
- A systematic review and meta-analysis of platelets prepared from apheresis versus whole blood. Transfusion. 190A-190A. 2007
- Development of a conceptual model to describe the experience of permanent donor deferral. Transfusion. 203A-203A. 2006
- A multicenter, randomized, controlled clinical pilot trial of the feasibility of an intensive RBC transfusion policy for patients with acute leukemia treated with induction chemotherapy or stem cell transplant.. Blood. 126B-126B. 2005
- Insights into the risk of bleeding in thrombocytopenic patients with acute leukemia. Transfusion. 12A-13A. 2005
- Patient self-assessment of bleeding symptoms. Transfusion. 145A-145A. 2005
- Proceedings of a Consensus Conference: Towards an Understanding of TRALI. Transfusion Medicine Reviews. 2-31. 2005
- Predictors of infection and bleeding in patients with chemotherapy induced thrombocytopenia. Blood. 556A-557A. 2003
- Comparison of methods for the analysis of bleeding outcomes in platelet transfusion studies. Transfusion. 31A-31A. 2003
- Window period HIV in a test-seeking blood donor: First p24 antigen positive donor in Canada without detectable anti-HIV antibodies. Transfusion. 118A-118A. 2003
- Patients with multiple myeloma transplanted with increased numbers of PBPC demonstrate early recovery of total lymphocytes.. Blood. 335B-335B. 2000
- The impact of idiopathic thrombocytopenic purpura in pregnancy.. Blood. 248A-248A. 2000
- Treatment of chronic refractory idiopathic thrombocytopenic purpura with cyclophosphamide and cyclosporine.. Blood. 253A-253A. 2000
-
journal articles
- Treatment of Critical Bleeds in Patients With Immune Thrombocytopenia: A Systematic Review.. European Journal of Haematology. 2024
- Healthcare provider's perceptions of bleeding in patients with acute leukaemia undergoing induction chemotherapy: A qualitative study. Transfusion Medicine. 34:268-277. 2024
- Obstetrical Use of Intravenous Immunoglobulin at a Tertiary Care Canadian Center: A 14-Year Retrospective Study. Blood. 142:5561-5561. 2023
- Platelet Count Response to Obstetrical Use of IVIG for Maternal Thrombocytopenia: A 14-Year Retrospective Study. Blood. 142:2583-2583. 2023
- Treatment of Critical Bleeding Events in Patients with Immune Thrombocytopenia: A Systematic Review. Blood. 142:7239-7239. 2023
- P‐BB‐8 | A Survey to Understand C1 Esterase Inhibitor Distribution Patterns and Use in Canada. Transfusion. 63:94A-95A. 2023
- A retrospective analysis of haemolytic reactions to intravenous immunoglobulin using data from the Transfusion‐Transmitted Injuries Surveillance System (Ontario). Vox Sanguinis. 118:753-762. 2023
- Pharmacist Integration into the Hemophilia Treatment Centre: A Canadian Pilot Project to Optimize Treatment and Improve Cost-Savings Using Pharmacokinetic Assessments of Hemophilia Patients. Blood. 138:832-832. 2021
- Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet Immunology. Journal of Thrombosis and Haemostasis. 19:2082-2088. 2021
-
A prospective multi‐faceted interventional study of blood bank technologist screening of red blood cell transfusion orders: The
START study. Transfusion. 61:410-422. 2021 - Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin. Transfusion. 58:2729-2735. 2018
- Quality of Evidence-Based Guidelines for Transfusion of Red Blood Cells and Plasma: A Systematic Review. Transfusion Medicine Reviews. 32:135-143. 2018
- A multicentred study to validate a consensus bleeding assessment tool developed by the biomedical excellence for safer transfusion collaborative for use in patients with haematological malignancy. Vox Sanguinis. 113:251-259. 2018
- Red blood cell storage and in-hospital mortality: a secondary analysis of the INFORM randomised controlled trial. The Lancet Haematology. 4:e544-e552. 2017
- The association between platelet transfusions and bleeding in critically ill patients with thrombocytopenia. Research and Practice in Thrombosis and Haemostasis. 1:103-111. 2017
- Effect of Short-Term vs. Long-Term Blood Storage on Mortality after Transfusion. New England Journal of Medicine. 375:1937-1945. 2016
- Evaluating appropriate red blood cell transfusions: a quality audit at 10 Ontario hospitals to determine the optimal measure for assessing appropriateness. Transfusion. 56:2466-2476. 2016
- AABB Committee Report: reducing transfusion‐transmitted cytomegalovirus infections. Transfusion. 56:1581-1587. 2016
- Red blood cell processing methods and in-hospital mortality: a transfusion registry cohort study. The Lancet Haematology. 3:e246-e254. 2016
- Red blood cell processing methods and in-hospital mortality: a transfusion registry cohort study. The Lancet Haematology. 3:E246-E254. 2016
- Public Perceptions of Pathogen Reduction Technology in the Canadian Donor Blood Supply. ISBT Science Series. 11:14-23. 2016
- Rationale and Design of the Informing Fresh versus Old Red Cell Management (INFORM) Trial: An International Pragmatic Randomized Trial. Transfusion Medicine Reviews. 30:25-29. 2016
- 2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium. Transfusion. 55:2282-2290. 2015
- A phase‐II sequential case‐series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab. British Journal of Haematology. 170:208-217. 2015
- The prevalence of anti‐K in Canadian prenatal patients. Transfusion. 55:1486-1491. 2015
- Splitting versus lumping: reconsidering the definition of transfusion‐related acute lung injury. Transfusion. 55:927-929. 2015
- Treatment decision‐making among Canadian youth with severe haemophilia: a qualitative approach. Haemophilia. 21:180-189. 2015
- Platelet Transfusion: A Clinical Practice Guideline From the AABB. ACP journal club. 162:205-213. 2015
- Risks, benefits and the role of stakeholders in pathogen reduction technology. Health, Risk & Society. 16:547-564. 2014
-
First analysis of 10‐year trends in national factor concentrates usage in haemophilia: data from
CHARMS , the Canadian Hemophilia Assessment and Resource Management System. Haemophilia. 20:e251-e259. 2014 - Implementation and public acceptability: lessons from food irradiation and how they might apply to pathogen reduction in blood products. Vox Sanguinis. 107:50-59. 2014
- Platelet Utilization: A Canadian Blood Services Research and Development Symposium. Transfusion Medicine Reviews. 28:84-97. 2014
- Transfusion-Related Acute Lung Injury. Indian Journal of Hematology and Blood Transfusion. 30:56-58. 2014
-
What should men living with haemophilia need to know? The perspectives of
C anadian men with haemophilia. Haemophilia. 20:219-225. 2014 - What should men living with severe haemophilia need to know? The perspectives of Canadian haemophilia health care providers. Haemophilia. 19:503-510. 2013
- Expert Approaches to Common Bleeding and Thrombotic Problems, Part II. Seminars in Thrombosis and Hemostasis. 39:113-116. 2013
- Ten-Year Canadian National Prospective Data On Utilization of Anti-Hemophilic Concentrates: Indications and Trends. Blood. 120:1186-1186. 2012
- A new tool to assess bleeding severity in patients with chemotherapy‐induced thrombocytopenia (CME). Transfusion. 52:2466-2474. 2012
-
Continuing Medical Education Program in
T ransfusion. Transfusion. 52:2465-2465. 2012 - Acquired Hemophilia A. Seminars in Thrombosis and Hemostasis. 38:735-741. 2012
- Expert Approaches to Common Bleeding and Thrombotic Problems—Part I. Seminars in Thrombosis and Hemostasis. 38:641-644. 2012
- The importance of haemophilia treatment centre administrators in patient care. Haemophilia. 18:e366-e367. 2012
- The effect of blood storage duration on in‐hospital mortality: a randomized controlled pilot feasibility trial. Transfusion. 52:1203-1212. 2012
- Low prevalence of inhibitor antibodies in the Canadian haemophilia population. Haemophilia. 18:e254-e259. 2012
- Transfusion-related acute lung injury in the Canadian paediatric population. Paediatrics and Child Health. 17:235-239. 2012
- Do expert assessments converge? An exploratory case study of evaluating and managing a blood supply risk. BMC International Health and Human Rights. 11:666. 2011
- Diagnostic Usefulness of a Lumi-Aggregometer Adenosine Triphosphate Release Assay for the Assessment of Platelet Function Disorders. American Journal of Clinical Pathology. 136:350-358. 2011
- Time to rethink clinically important outcomes in platelet transfusion trials. Transfusion. 51:430-434. 2011
- Cerebral Venous Thrombosis During Pregnancy in the Setting of Type I Antithrombin Deficiency: Case Report and Literature Review. Transfusion Medicine Reviews. 25:61-65. 2011
- Cerebral Venous Thrombosis During Pregnancy in the Setting of Type I Antithrombin Deficiency: Case Report and Literature Review.. Blood. 114:4447-4447. 2009
- Diagnostic Utility of Platelet Secretion Testing by ATP Release Assays: Results From a Prospective Study of Individuals Referred for Bleeding Disorder Assessments.. Blood. 114:1314-1314. 2009
- Pilot trials in transfusion medicine. Transfusion. 49:1293-1295. 2009
- Transfusion Related Acute Lung Injury in the Canadian Paediatric Population. Paediatrics and Child Health. 14:55A-55A. 2009
- Diagnostic utility of light transmission platelet aggregometry: results from a prospective study of individuals referred for bleeding disorder assessments. Journal of Thrombosis and Haemostasis. 7:676-684. 2009
- Severe Hemolytic Anemia Post–Renal Transplantation Produced by Donor Anti-D Passenger Lymphocytes: Case Report and Literature Review. Transfusion Medicine Reviews. 23:155-159. 2009
- CONSORT comes to TRANSFUSION. Transfusion. 49:194-195. 2009
- Factors affecting the frequency of red blood cell outdates: an approach to establish benchmarking targets. Transfusion. 49:219-226. 2009
- A policy informing qualitative study to improve the process of blood product recalls and withdrawals. Transfusion. 48:2585-2595. 2008
- Consequences of transfusion of platelet antibody: a case report and literature review. Transfusion. 48:1981-1989. 2008
- Comparing the efficacy and safety of apheresis and whole blood–derived platelet transfusions: a systematic review. Transfusion. 48:1447-1458. 2008
- On-Label Versus Off-Label Use of Recombinant Activated Factor VII: A Comprehensive Review of Use in Two Canadian Centers. Seminars in Hematology. 45:S68-S71. 2008
- A multicenter pilot‐randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation. Transfusion. 48:81-91. 2008
- An evaluation of methods for determining reference intervals for light transmission platelet aggregation tests on samples with normal or reduced platelet counts. Thrombosis and Haemostasis. 100:01-12. 2008
- Proceedings of a Consensus Conference: Pathogen Inactivation—Making Decisions About New Technologies. Transfusion Medicine Reviews. 22:1-34. 2008
- Understanding the meaning of permanent deferral for blood donors. Transfusion. 48:64-72. 2008
- Treatment allocation in clinical trials. Transfusion. 47:2187-2188. 2007
- Gender Differences in Bleeding Problems and Implications for the Assessment of a Bleeding Disorder.. Blood. 110:2148-2148. 2007
- Randomization in clinical trials. Transfusion. 47:1753-1754. 2007
- Utilization of recombinant activated factor VII in southern Ontario in 85 patients with and without haemophilia. Haemophilia. 13:518-526. 2007
- Trends in the utilization and wastage of coagulation factor concentrates: the application of a regional tracking programme. Haemophilia. 13:271-278. 2007
- Bleeding during critical illness: A prospective cohort study using a new measurement tool. Clinical and Investigative Medicine. 30:93-93. 2007
- A study of the agreement between patient self‐assessment and study personnel assessment of bleeding symptoms. Transfusion. 46:1926-1933. 2006
- The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia. Haematologica. 91:1530-1537. 2006
- The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia.. Haematologica. 91:1530-1537. 2006
- LETTERS TO THE EDITOR. Journal of Trauma and Acute Care Surgery. 60:242-243. 2006
- A Multicenter, Randomized, Controlled Clinical Pilot Trial of the Feasibility of an Intensive RBC Transfusion Policy for Patients with Acute Leukemia Treated with Induction Chemotherapy or Stem Cell Transplant.. Blood. 106:4183-4183. 2005
- Transfusion-related acute lung injury. Current Opinion in Hematology. 12:480-487. 2005
- Hypotensive transfusion reactions can occur with blood products that are leukoreduced before storage. Transfusion. 44:1361-1366. 2004
- Methods for the analysis of bleeding outcomes in randomized trials of PLT transfusion triggers. Transfusion. 44:1135-1142. 2004
- Proceedings of a consensus conference: the screening of blood donors for variant CJD1 1This Consensus Conference took place at the Ritz Carlton Hotel in Montreal, Quebec, on March 26–28, 2003, and was chaired by Dr. Gilles Delage of Héma Québec.. Transfusion Medicine Reviews. 18:73-92. 2004
- A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood. 102:4306-4311. 2003
- Role of the Hct in the treatment of thrombocytopenic patients. Transfusion. 43:1761-1762. 2003
- The above letter was sent to Heddle et al.: Dr Heddle offered the following reply. Transfusion. 43:1763-1763. 2003
- Transfusion-related acute lung injury. Transfusion Medicine Reviews. 17:252-262. 2003
- Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies. Transfusion. 43:742-752. 2003
- Proceedings of a consensus conference: Blood-borne HIV and hepatitis—Optimizing the donor selection process†. Transfusion Medicine Reviews. 17:1-30. 2003
- Zoledronic acid: An overview of its current and potential benefits in patients with malignancy. Today's Therapeutic Trends. 20:197-219. 2002
- Patients with multiple myeloma transplanted with increased numbers of pbpc demonstrate early recovery of total lymphocytes. Blood. 96. 2000
- The impact of idiopathic thrombocytopenic purpura in pregnancy. Blood. 96. 2000
- Treatment of chronic refractory idiopathic thrombocytopenic purpura with cyclophosphamide and cyclosporine. Blood. 96. 2000
- Effects of inhaled nitric oxide in a rat model of Pseudomonas aeruginosa pneumonia. Critical Care Medicine. 28:2397-2405. 2000
- The use of electron microscopy in the investigation of the ultrastructural morphology of immune thrombocytopenic purpura platelets. Seminars in Hematology. 37:222-228. 2000
- The use of electron microscopy in the investigation of the ultrastructural morphology of immune thrombocytopenic purpura platelets. Seminars in Hematology. 37:222-228. 2000
- GENDER DIFFERENCES IN BLEEDING PROBLEMS AND IMPLICATIONS FOR THE ASSESSMENT OF A BLEEDING DISORDER. Clinical and Investigative Medicine. 31:18-18.